PW has repeatedly taken measures to maintain the appearance of steady growth in sales and profits. For example, tax deferral to other years, changing reporting from quarterly to half-yearly, high interest income through high savings accounts.
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4D and Half Year Report
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.20%
!
$9.81

Ann: Appendix 4D and Half Year Report, page-71
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.81 |
Change
-0.020(0.20%) |
Mkt cap ! $492.2M |
Open | High | Low | Value | Volume |
$9.89 | $9.99 | $9.66 | $820.3K | 83.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 109 | $9.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.81 | 65 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 157 | 9.780 |
3 | 206 | 9.770 |
4 | 293 | 9.760 |
4 | 211 | 9.750 |
5 | 266 | 9.740 |
Price($) | Vol. | No. |
---|---|---|
9.820 | 153 | 7 |
9.830 | 82 | 3 |
9.840 | 182 | 4 |
9.850 | 466 | 3 |
9.860 | 209 | 2 |
Last trade - 15.23pm 16/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |